Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Coating for Vascular Grafts Dissolves Blood Clots

By HospiMedica International staff writers
Posted on 24 Aug 2015
A novel thrombolytic coating for vascular grafts could obviate the need for continuous use of anticoagulants, according to a new study. More...


Researchers at ITMO University (St. Petersburg, Russia) and Petrozavodsk State University (Russia) have developed a new family of injectable composites for treating thrombolysism composed of urokinase plasminogen activator entrapped within alumina. The thrombolytic coating is a sol-gel made of nanocrystalline oxides, and can thus lock the necessary thrombolytic enzymes inside the polymer vascular graft, making the productive lifespan of the graft virtually limitless.

The nanoarchitecture of the sol-gel thrombolytic coating is also bio-inert, ensuring near perfect stability. According to the researchers, the alumina, which serves as the urokinase plasminogen activator carrier, helps to prolong its activity in vivo and reduce the total administered dose of anticoagulant drugs necessary following a stent graft procedure, and hence the eventual side effects, such as the danger of hemorrhagic stroke. The study was published on August 13, 2015, in the Journal of Medicinal Chemistry.

“Modern vascular grafts are medicated and they emit the drug into the bloodstream; however, the concentration of the medication in the graft decreases with time and then clots may reappear. This coating provides unhampered bloodstream preventing thrombosis,” said lead author Yulia Chapurina, MSc, of the ITMO laboratory of solution chemistry of advanced materials and technologies. “The new technology is based on drug entrapping. It means that the protective coating holds it inside the vascular graft.”

The sol-gel process is a method for producing solid materials from small molecules, and is used for the fabrication of metal oxides, especially the oxides of silicon and titanium. In the procedure, the 'sol' (solution) gradually evolves towards the formation of a gel-like diphasic system containing both a liquid phase and solid phase whose morphologies range from discrete particles to continuous polymer networks. The unique properties of the sol-gel provide the possibility of their use for a variety of medical applications.

Related Links:

ITMO University
Petrozavodsk State University



New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
New
Digital Radiography System (Ceiling Free)
Digix CF Series
New
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.